Literature DB >> 22691675

Rapidly destructive arthropathy of the hip joint in patients with rheumatoid arthritis.

Ho Hyun Yun1, Seung Yeop Song, Sung Bum Park, Jee Wun Lee.   

Abstract

This article describes 3 patients with rheumatoid arthritis in which hip joint conditions were similar to rapidly destructive arthropathy of the hip joint. The patients had the following additional characteristics: (1) age at diagnosis was comparatively older; (2) rheumatoid arthritis had an onset after age 40 years; (3) severe rheumatoid arthritis was present in >4 major joints; (4) long-term steroids and disease-modifying antirheumatic drugs were taken due to the high activity of rheumatoid arthritis; and (5) patients were underweight, with body mass indexes <20 kg/m(2).Rapidly destructive arthropathy of the hip joint rarely occurs in osteoarthritis, avascular necrosis of the femoral head, and rheumatoid arthritis. Clinically, rapidly destructive arthropathy of the hip joint occurs in elderly patients who report severe pain but have a relatively preserved range of motion. Typical radiologic changes in rapidly destructive arthropathy of the hip joint are rapid destruction, resorption, or subluxation of the femoral head, destruction of the acetabulum, and minimal spur formation developing 6 to 12 months after symptom onset. Destruction of the hip joint in rheumatoid arthritis occurs in the sequence of depression, flattening, and loss, and commonly progresses gradually. When patients with rheumatoid arthritis report persistent and severe pain in the hip joint with no specific cause, rapidly destructive arthropathy of the hip joint must be identified through repetitive follow-up radiographic observations. Copyright 2012, SLACK Incorporated.

Entities:  

Mesh:

Year:  2012        PMID: 22691675     DOI: 10.3928/01477447-20120525-42

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  1 in total

1.  Rapidly destructive inflammatory arthritis of the hip.

Authors:  Jenny Shu; Ian Ross; Bret Wehrli; Richard W McCalden; Lillian Barra
Journal:  Case Rep Rheumatol       Date:  2014-07-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.